<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37150660</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2623</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Transplantation proceedings</Title><ISOAbbreviation>Transplant Proc</ISOAbbreviation></Journal><ArticleTitle>Long Covid as an Indication for Heart Transplantation and Its Characteristics.</ArticleTitle><Pagination><StartPage>1870</StartPage><EndPage>1872</EndPage><MedlinePgn>1870-1872</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.transproceed.2023.03.071</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0041-1345(23)00239-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The post-acute cardiovascular manifestations of COVID-19, known as long COVID, have yet to be comprehensively characterized. There is also an increased risk of heart failure in individuals without cardiovascular disease before SARS-CoV-2 infection. The literature lacks information regarding the characteristics of patients with long COVID who developed advanced heart failure refractory to guideline-directed&#xa0;medical therapy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We describe the characteristics of patients with long COVID (LC) who were listed for heart transplantation. The study population comprised 45 patients listed for heart transplantation, divided into 2 groups: patients with etiologies other than LC (n&#xa0;=&#xa0;41) and patients with LC (n&#xa0;=&#xa0;4) between January 2020 and March 2022. The endpoint of this study was the description of the characteristics of each group.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The average duration of hospitalization after the acute infectious episode with SARS-CoV-2 was 150 &#xb1; 113 days, and all patients were hospitalized in New York Heart Association class IV. All LC patients were oligosymptomatic in the initial infection, did not require hospitalization in the acute phase, had a lower ejection fraction, used more intra-aortic balloon pumps, had lower pulmonary vascular resistance, and fewer comorbidities compared with other etiologies, suggesting a clinical feature compatible with low cardiac output rather than congestion.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study is an early investigation of patients listed for heart transplantation due to a complex syndrome of COVID-19. These preliminary findings warrant further large-scale investigation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rossi Neto</LastName><ForeName>Joao Manoel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil. Electronic address: jmrossi@sti.com.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Raphael Machado</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolf</LastName><ForeName>Plinio Jose Whitaker</ForeName><Initials>PJW</Initials><AffiliationInfo><Affiliation>Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Mello</LastName><ForeName>Victor Bemfica</ForeName><Initials>VB</Initials><AffiliationInfo><Affiliation>Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dantas</LastName><ForeName>Daniel Chagas</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Carolina Casadei Dos</ForeName><Initials>CCD</Initials><AffiliationInfo><Affiliation>Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finger</LastName><ForeName>Marco Aurelio</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transplant Proc</MedlineTA><NlmUniqueID>0243532</NlmUniqueID><ISSNLinking>0041-1345</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016027" MajorTopicYN="Y">Heart Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>7</Day><Hour>21</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37150660</ArticleId><ArticleId IdType="pmc">PMC10160848</ArticleId><ArticleId IdType="doi">10.1016/j.transproceed.2023.03.071</ArticleId><ArticleId IdType="pii">S0041-1345(23)00239-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Kute V, Meshram HS, Fleetwood VA, Chauhan S, Lentine KL. Solid organ transplantation in SARS-CoV-2 recovered transplant candidates: a comprehensive review of recent literature. Curr Transplant Rep. 2022;9:95&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8904162</ArticleId><ArticleId IdType="pubmed">35284204</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro ALP, Duncan BB, Brant LCC, Lotufo PA, Mill JG, Barreto SM. Cardiovascular health in Brazil: trends and perspectives. Circulation. 2016;133:422&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">26811272</ArticleId></ArticleIdList></Reference><Reference><Citation>Girerd N, Chapet N, Roubille C, Roncalli J, Salvat M, Mouquet F, et al. Vaccination for respiratory infections in patients with heart failure. J Clin Med. 2021;10:4311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8509310</ArticleId><ArticleId IdType="pubmed">34640328</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson KW, Patel S, Thapi S, Jaladanki SK, Rao A, Nirenberg S, et al. Association of reduced hospitalizations and mortality among COVID-19 vaccinated patients with heart failure. J Card Fail. 2022;28:1475&#x2013;1479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9178679</ArticleId><ArticleId IdType="pubmed">35691478</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>